Article Details
Retrieved on: 2025-04-07 17:43:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
3. Tremfya (guselkumab) real-world data analyses show greater treatment persistence than IL-17s in both bio-naïve and bio-experienced patients ...
Article found on: www.appliedclinicaltrialsonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here